A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

A recent review confirms the safety and efficacy of biosimilar insulins, addressing concerns and promoting their adoption for ...

Now, a study of 170,000 patient records suggests there's a slightly lower risk of obesity-related cancers in U.S. adults with diabetes who took these popular medications compared to those who took ...

ALSO SEE: New Type 1 diabetes drug gives hope to millions of Americans. Despite the early stage of the study, the results reverberated on Wall Street, sending stocks of companies that make ...

GLP-1 medications such as Ozempic and Wegovy may help lower the risk of certain cancers, a new study suggests. People who are overweight or obese have a higher risk of getting 13 types of cancer ...

AdventHealth researchers are seeking participants for a study that will attempt to identify people with type 1 diabetes early in their disease.

The study included 31,229 dementia-free adult United Kingdom Biobank participants aged 40 to 70 years. Exclusion criteria included chronic neurological disorders, insulin-dependent diabetes, and ...

In 2022, there were around 828 million people aged 18 years and older with type 1 and type 2 diabetes worldwide, the study found. Among adults aged 30 years and older, 445 million, ...